LULY JAY R. (President and CEO) reported 1 transaction at ENANTA PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 12/3/2025ACC: 0002064832-25-000042
DirectorOfficer· President and CEO
Since Jul 2018
-1.89K
Net shares
Net seller
$26.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.89K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.89K
Price / share
$14.12
Trade value
$26.62K
% of position
0.2%
12/1/2025
864.65K→862.77K
Total
Net shares
−1.89K
Net value
-$26.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2025 | F · Tax Withholding | −1.89K | $14.12 | $26.62K | 0.2% | 864.65K | 862.77K |
| Total | −1.89K | -$26.62K | ||||||
Derivative Transactions0
No derivative transactions reported